<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="187">
  <!-- This xml conforms to:  http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>Information obtained from ClinicalTrials.gov on October 20, 2011</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01204944</url>
  </required_header>
  <id_info>
    <org_study_id>3347C0-108795/1</org_study_id>
    <nct_id>NCT01204944</nct_id>
  </id_info>
  <brief_title>Swiss Transplant Cohort Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Schweizerischer Nationalfonds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Swiss Transplant Cohort Study is an observational pospective cohort study enrolling all
      patients after solid organ and stem cell (planned 2009) transplantation in Switzerland.
      Predefined variables will be collected at defined time points. Individual samples (PBMC,
      plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome
      with emphasis on immunological and infectious complications as well as psychosocial
      variables will be gathered.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model:  Cohort, Time Perspective:  Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>All Transplanted Indivduals in Switzerland</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All transplanted indivduals in Switzerland
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  All patients after organ  and stem cell (planned 2009) transplantation.

        Exclusion criteria:

          -  No informed consent given
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <phone>+41 (0)44 255 11 11</phone>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <lastchanged_date>September 16, 2010</lastchanged_date>
  <firstreceived_date>September 16, 2010</firstreceived_date>
  <responsible_party>
    <name_title>PD Dr. med. Nicolas Mueller</name_title>
    <organization>University Hospital Zurich, INF Klinik f. Infektionskrankh.&amp;Spitalhygiene</organization>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
</clinical_study>
